You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hydrochlorothiazide

Showing 1 - 25 of 523
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes in Adults Trial in Shanghai (Hydrochlorothiazide?Henagliflozin Proline)

Completed
  • Diabetes in Adults
  • Hydrochlorothiazide、Henagliflozin Proline
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 12, 2023

Kidney Stone Trial in Bern (Indapamide 2.5 MG, Hydrochlorothiazide 50Mg, Chlorthalidone 25mg)

Not yet recruiting
  • Kidney Stone
  • Indapamide 2.5 MG
  • +2 more
  • Bern, Switzerland
    Inselspital, Department of Nephrology and Hypertension
Oct 26, 2023

Urolithiasis, Hyperoxaluria Trial in Vienna (Dapagliflozin, Hydrochlorothiazide)

Not yet recruiting
  • Urolithiasis
  • Hyperoxaluria
  • Vienna, Austria
    Medical University of Vienna
Jun 29, 2022

Primary Hypertension Trial (Amlodipine, Olmesartan, Hydrochlorothiazide)

Not yet recruiting
  • Primary Hypertension
  • (no location specified)
Jun 15, 2023

Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide

Recruiting
  • Obesity, Morbid
  • Hydrochlorothiazide
  • Trondheim, Norway
    St. Olavs University Hospital
Apr 1, 2022

Bioequivalence Trial in Moscow (Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg, Tritace® Plus tablet 10 mg/25 mg)

Not yet recruiting
  • Bioequivalence
  • Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
  • Tritace® Plus tablet 10 mg/25 mg
  • Moscow, Russian Federation
    Separate medical division "Comed" (Ligand Research LLC)
Jan 5, 2023

Patients Treated With Telmisartan/Hydrochlorothiazide or

Withdrawn
  • Hypertension
  • subjects treated with telmisartan/hydrochlorothiazide
  • +3 more
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022

Blood Pressure, Diabetes, Obesity Trial in Kansas City (Hydrochlorothiazide 12.5Mg Tab, Clonidine Pill, Placebo)

Recruiting
  • Blood Pressure
  • +5 more
  • Hydrochlorothiazide 12.5Mg Tab
  • +2 more
  • Kansas City, Kansas
    University of Kansas Medical Center
Jun 15, 2022

ive Alzheimer's Medicines- Dihydropyridine Calcium Channel

Active, not recruiting
  • Hypertension
  • Dihydropyridine calcium channel blocker
  • Hydrochlorothiazide
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 1, 2022

Pre-Eclampsia, Gestational Hypertension, Superimposed Pre-Eclampsia Trial in Austin, Galveston (Hydrochlorothiazide 50mg Tablet,

Recruiting
  • Pre-Eclampsia
  • +5 more
  • Hydrochlorothiazide 50mg Tablet
  • Placebo Tablet
  • Austin, Texas
  • +1 more
Feb 10, 2022

Resistant Hypertension Trial in Guangzhou (Sacubitril/valsartan, valsartan)

Recruiting
  • Resistant Hypertension
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 16, 2022

ADPKD Trial in Worldwide (Hydrochlorothiazide 25 mg, Placebo)

Not yet recruiting
  • ADPKD
  • Hydrochlorothiazide 25 mg
  • Placebo
  • Boston, Massachusetts
  • +12 more
May 10, 2022

Hypertension Trial in Lancaster (Salt loading, Hydrochlorothiazide (HCTZ))

Completed
Has Results
  • Hypertension
  • Salt loading
  • Hydrochlorothiazide (HCTZ)
  • Lancaster, Pennsylvania
    Amish Research Clinics
Mar 23, 2022

Nephrolithiasis Trial in Switzerland (Placebo oral capsule, 12.5 mg hydrochlorothiazide, 25.0 mg hydrochlorothiazide)

Active, not recruiting
  • Nephrolithiasis
  • Placebo oral capsule
  • +3 more
  • Aarau, Switzerland
  • +11 more
Jan 17, 2022

Photosensitivity Trial in Homburg (Hydrochlorothiazide, Placebo)

Completed
  • Photosensitivity
  • Hydrochlorothiazide
  • Placebo
  • Homburg, Saarland, Germany
    Saarland University Hospital
Nov 18, 2021

Arterial Hypertension Trial (Olmesartan medoxomil 40mg + chlorthalidone 12,5mg, Olmesartan medoxomil 40mg + chlorthalidone 25mg,

Not yet recruiting
  • Arterial Hypertension
  • Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
  • +3 more
  • (no location specified)
Aug 3, 2022

Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,

Not yet recruiting
  • Essential Hypertension
  • Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
  • Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
  • Seoul, Gyeonggi-do, Korea, Republic of
  • +11 more
Sep 11, 2023

Hypertension Trial (losartan potassium, Comparator: carvedilol, Comparator: losartan (+) hydrochlorothiazide (HCTZ))

Completed
Has Results
  • Hypertension
  • losartan potassium
  • +3 more
  • (no location specified)
Feb 7, 2022

Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks)

Completed
  • Hypertension
  • MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks
  • (no location specified)
Feb 7, 2022

Hypertension in Pregnancy, Postpartum Preeclampsia Trial in Houston (ACE Inhibitors and Diuretics, NIFEdipine ER)

Recruiting
  • Hypertension in Pregnancy
  • Postpartum Preeclampsia
  • ACE Inhibitors and Diuretics
  • NIFEdipine ER
  • Houston, Texas
    University of Texas Health Science Center
Oct 22, 2021

Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Recruiting
  • Hypertension,Essential
    • Seoul, Korea, Republic of
      Seoul National University Bundang Hospital
    Jul 7, 2022

    Essential Arterial Hypertension Trial in Mexico City (Losartan/Chlorthalidone in fixed dose, Losartan + hydrochlorothiazide in

    Not yet recruiting
    • Essential Arterial Hypertension
    • Losartan/Chlorthalidone in fixed dose
    • Losartan + hydrochlorothiazide in fixed dose
    • Mexico City, Mexico
      Laboratorio Silanes, S.A. de C.V.
    Jul 5, 2021

    Pediatric Hypertension Trial in Houston (NICHE method, Usual care, Amlodipine)

    Completed
    Has Results
    • Pediatric Hypertension
    • NICHE method
    • +5 more
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Aug 16, 2022

    Hypertension Trial in Shanghai (losartan/hydrochlorothiazide, amlodipine/hydrochlorothiazide)

    Recruiting
    • Hypertension
    • Shanghai, China
      Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
    Mar 16, 2021

    Chronic Kidney Disease, Hypertension Trial in Houston (Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide,

    Not yet recruiting
    • Chronic Kidney Disease
    • Hypertension
    • Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)
    • Houston, Texas
      Michael E. DeBakey VA Medical Center, Houston, TX
    Aug 3, 2022